(Q48018311)

7 February 2018

title

Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer (English)

1 reference

7 February 2018

author name string

Murphy GP

1

1 reference

7 February 2018

Kenny GM

2

1 reference

7 February 2018

Ragde H

3

1 reference

7 February 2018

Wolfert RL

4

1 reference

7 February 2018

Boynton AL

5

1 reference

7 February 2018

Holmes EH

6

1 reference

7 February 2018

Misrock SL

7

1 reference

7 February 2018

Bartsch G

8

1 reference

7 February 2018

Klocker H

9

1 reference

7 February 2018

Pointner J

10

1 reference

7 February 2018

Reissigl A

11

1 reference

7 February 2018

McLeod DG

12

1 reference

7 February 2018

Douglas T

13

1 reference

7 February 2018

Morgan T

14

1 reference

7 February 2018

Gilbaugh J Jr

15

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

7 February 2018

published in

Urology

1 reference

7 February 2018

volume

51

1 reference

7 February 2018

issue

5A Suppl

1 reference

7 February 2018

page(s)

89-97

1 reference

7 February 2018

Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900082-X

7 January 2021

Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900082-X

7 January 2021

Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900082-X

7 January 2021

Dissociation of PDGF receptor tyrosine kinase activity from PDGF-mediated inhibition of gap junctional communication

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900082-X

7 January 2021

Disagreement between the Roche Cobas Core and Hybritech TANDEM-E PSA assays when measuring free, complexed and total serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900082-X

7 January 2021

Basic principles of ROC analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900082-X

7 January 2021

Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900082-X

7 January 2021

Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900082-X

7 January 2021

Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900082-X

7 January 2021

10.1016/S0090-4295(98)00082-X

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018